Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis

Critical Care Medicine

Volumn 38, Issue 5, 2010, Pages 1335-1342

  Zou, Lin ^a,c   Feng, Yan ^a   Chen, Yu Jung ^a   Si, Rui ^a   Shen, Shiqian ^a   Zhou, Qichang ^c   Ichinose, Fumito ^a   Scherrer Crosbie, Marielle ^b   Chao, Wei ^a  

^a Department of Anesthesia and Critical Care ^*  (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cardiac dysfunction; Inflammation; Neutrophils; Sepsis; Toll like receptor 2

Indexed keywords

CALCIUM; CHEMOKINE RECEPTOR; CYTOKINE; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CARDIOMYOPATHY; CATHETER; CECUM; CELL ISOLATION; CELL MIGRATION; CLINICAL RESEARCH; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; LABORATORY; LAPAROTOMY; LEUKOCYTE COUNT; LIGATION; MALE; MODEL; MORTALITY; MOUSE; MYOCARDITIS; NEUTROPHIL; NONHUMAN; PERITONITIS; PRESSURE TRANSDUCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUNCTURE; SARCOMERE; SEPSIS; SHAM PROCEDURE; SURGICAL TECHNIQUE; SURVIVAL RATE; TISSUE DOPPLER IMAGING; UNIVERSITY HOSPITAL; WILD TYPE;

ANIMALS; CELL MOVEMENT; CYTOKINES; HEART DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; NEUTROPHILS; PERITONITIS; SEPSIS; TOLL-LIKE RECEPTOR 2;

EID: 77951620500     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181d99e67     Document Type: Article

References (42)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United Stat es: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244-1250
3. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
4. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
5. Flierl MA, Rittirsch D, Huber-Lang MS, et al: Molecular events in the cardiomyopathy of sepsis. Mol Med 2008; 14:327-336
6. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-145
7. Alves-Filho JC, Freitas A, Souto FO, et al: Regulation of chemokine receptor by Tolllike receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA 2009; 106: 4018-4023
8. Plitas G, Burt BM, Nguyen HM, et al: Tollmlike receptor 9 inhibition reduces mortality in polymicrobial sepsis. J Exp Med 2008; 205:1277-1283
9. Chao W: Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009; 296:H1-H12
10. Frantz S, Kobzik L, Kim YD, et al: Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999; 104:271-280
11. Knuefermann P, Sakata Y, Baker JS, et al: Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 2004; 110:3693-3698
12. Nemoto S, Vallejo JG, Knuefermann P, et al: Escherichia coli LPS-induced LV dysfunction: Role of toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol 2002; 282:H2316-H2323
13. Zhu X, Bagchi A, Zhao H, et al: Toll-like receptor 2 activation by bacterial peptidogly-can-associated lipoprotein activates cardio-myocyte inflammation and contractile dysfunction. Crit Care Med 2007; 35:886-892
14. Takeuchi O, Hoshino K, Kawai T, et al: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443-451
15. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery 1979; 85:205-211
16. Baker CC, Chaudry IH, Gaines HO, et al: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94:331-335
17. Feigenbaum H, Popp RL, Wolfe SB, et al: Ultrasound measurements of the left ventricle. A correlative study with angiocardiography. Arch Intern Med 1972; 129:461-467
18. Hataishi R, Rodrigues AC, Neilan TG, et al: Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 291:H379-H384
19. Sebag IA, Handschumacher MD, Ichinose F, et al: Quantitative assessment of regional myocardial function in mice by tissue Dopp-ler imaging: Comparison with hemodynamics and sonomicrometry. Circulation 2005; 111:2611-2616
20. Feng Y, Zhao H, Xu X, et al: Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 2008; 295:H1311-H1318
21. Zhu X, Zhao H, Graveline AR, et al: MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes. Am J Physiol Heart Circ Physiol 2006; 291: H1900-H1909
22. Ichinose F, Buys ES, Neilan TG, et al: Car-diomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res 2007; 100:130-139
23. von Meyenburg C, Hrupka BH, Arsenijevic D, et al: Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia. Am J Physiol Regul Integr Comp Physiol 2004; 287:R298-R305
24. Parrillo JE: Septic shock-vasopressin, nor-epinephrine, and urgency. N Engl J Med 2008; 358:954-956
25. Fernandes CJ Jr, Akamine N, Knobel E: Myo-cardial depression in sepsis. Shock 2008; 30(Suppl 1):14-17
26. Hotchkiss RS, Coopersmith CM, McDunn JE, et al: The sepsis seesaw: Tilting toward im-munosuppression. Nat Med 2009; 15: 496-497
27. Remick DG, Newcomb DE, Bolgos GL, et al: Comparison of the mortality and inflammatory response of two models of sepsis: Lipo-polysaccharide vs. cecal ligation and puncture. Shock 2000; 13:110-116
28. Hotchkiss RS, Swanson PE, Cobb JP, et al: Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T-and B-cell-deficient mice. Crit Care Med 1997; 25:1298-1307
29. Liang MD, Bagchi A, Warren HS, et al: Bacterial peptidoglycan-associated lipoprotein: A naturally occurring toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J Infect Dis 2005; 191:939-948
30. Urheim S, Edvardsen T, Torp H, et al: Myo-cardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 2000; 102:1158-1164
31. Greenberg NL, Firstenberg MS, Castro PL, et al: Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 2002; 105:99-105
32. Gorcsan J III, Strum DP, Mandarino WA, et al: Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiogra-phy. Comparison with sonomicrometry and pressure-v olume relations. Circulation 1997; 95:2423-2433
33. Goldfarb RD, Glock D, Kumar A, et al: A porcine model of peritonitis and bacteremia simulates human septic shock. Shock 1996; 6:442-451
34. Casey LC, Balk RA, Bone RC: Plasma cyto-kine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
35. Peck-Palmer OM, Unsinger J, Chang KC, et al: Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J Leukoc Biol 2008; 83:1009-1018
36. Simon SI, Green CE: Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 2005; 7:151-185
37. Alves-Filho JC, de Freitas A, Spiller F, et al: The role of neutrophils in severe sepsis. Shock 2008; 30(Suppl 1):3-9
38. Cohen J: The immunopathogenesis of sepsis. Nature 2002;420:885-891
39. Allen SJ, Crown SE, Handel TM: Chemokine: Receptor structure, interactions, and antagonism. Annu Rev Immunol 2007; 25: 787-820
40. Neel NF, Schutyser E, Sai J, et al: Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev 2005; 16:637-658
41. Khandaker MH, Mitchell G, Xu L, et al: Met-alloproteinases are involved in lipopolysac-charide-and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 1999; 93:2173-2185
42. Asagoe K, Yamamoto K, Takahashi A, et al: Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J Immunol 1998; 160:4518-4525